PTC Therapeutics | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
Daiichi Sankyo JPY 484.84B 38.29B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
Ironwood Pharmaceuticals USD 90.54M 1.05M 2024-12
Novartis USD 13.15B 330M 2024-12
Pfizer USD 17.76B 61M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
TG Therapeutics USD 108.18M 24.31M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12
Xencor USD 70.02M 59.31M 2024-12



PTC Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.